PORTLAND, Ore. (KOIN) — Oregon Health and Science University is recruiting Portlanders for a COVID-19 vaccine trial.
OHSU is looking for Portland-area residents to participate in a research study evaluating a potential vaccine developed by Oxford University and AstraZeneca, referred to as the AZD1222 COVID-19 vaccine study. OHSU is the only institution in the state involved in a Phase 3 clinical trial for the potential vaccine.
“Oregon Health & Science University is proud to contribute to the world’s most pressing challenge right now: identifying a safe and effective COVID-19 vaccine for everyone,” OHSU President Danny Jacobs said. “We’re asking Portland-area residents to volunteer for this trial and help bring all of us closer to stopping this devastating pandemic.”
Dr. Marcel Curlin, OHSU’s lead researcher for the clinical study, said AstraZeneca’s vaccine is much safer than vaccines in the past because the actual COVID virus is not used to make it. Asked if he would be comfortable taking this vaccine, Curlin had a short and ready answer.
“Yes, I would.”
He explained that what they’re doing “is something carefully designed to be safe and educate the immune system without being exposed to COVID. So that’s something different and I would personally be comfortable taking these vaccines.”
The trial is seeking a total of 30,000 participants to enroll. The participants will evaluate the
safety and effectiveness of the vaccine, with two injections administered about four weeks apart. Patients will then be monitored for two years.
According to OHSU, the study will strive to “enroll a diverse group of trial participants, and prioritizes the enrollment of individuals who are older than 55 years and Black, Indigenous and People of Color” in order to ensure the vaccine works well for the broadest group of people possible.
OHSU says participants must be 18 or older, not be pregnant, have either stable medical conditions or no medical issues, have not been previously diagnosed with COVID-19 and should live within
about 1.5 hours of OHSU’s Marquam Hill/South Waterfront campus. Those interested in enrolling can visit this website or call 888.822.7839.
More than 70,000 COVID-19 cases have been reported in Oregon since February; more than 900 Oregonians have lost their lives to the virus.